Metraipolis › archive › dc_d93ac38fb0fb

A Prospective Study on the Metabolic and Hormonal Outcomes of SGLT2 Inhibitor Combination Therapy With and Without Metformin in Newly Diagnosed Type 2… — Europe PMC PMID:42351629

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42351629
DOI
10.3390/biomedicines14061201
License (as archived)
solo-consultazione
Archived
2026-11-01T06:05:23.939Z
SHA-256 of the archived text
672d961c6b5da1389bc711f8c91cb49ea79dfac425803e3b25e20fc6d9a36f93
Stable URL of this page
https://metraipolis.com/documento/dc_d93ac38fb0fb

How to cite

A Prospective Study on the Metabolic and Hormonal Outcomes of SGLT2 Inhibitor Combination Therapy With and Without Metformin in Newly Diagnosed Type 2… — Europe PMC PMID:42351629 — Europe PMC (en), https://europepmc.org/article/MED/42351629 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d93ac38fb0fb (Metraipolis archive dc_d93ac38fb0fb, sha256 672d961c6b5da1389bc711f8c91cb49ea79dfac425803e3b25e20fc6d9a36f93)
BibTeX
@misc{dcd93ac38fb0fb,
  title = {A Prospective Study on the Metabolic and Hormonal Outcomes of SGLT2 Inhibitor Combination Therapy With and Without Metformin in Newly Diagnosed Type 2… — Europe PMC PMID:42351629},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42351629},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d93ac38fb0fb; sha256 672d961c6b5da1389bc711f8c91cb49ea79dfac425803e3b25e20fc6d9a36f93},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42351629. Agents can read the archived copy with the MCP tool read_document.